We are live on ! Find out more
NMTR

9 Meters Biopharma
NMTR

Delisted

NMTR was delisted on the 25th of July, 2023.

Back to rankings

74 hedge funds and large institutions have $10.4M invested in 9 Meters Biopharma in 2022 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 19 increasing their positions, 16 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,309% more call options, than puts

Call options by funds: $324K | Put options by funds: $23K

19% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 16

16% less funds holding

Funds holding: 88 → 74 (-14)

20% less capital invested

Capital invested by funds: $13M → $10.4M (-$2.6M)

50% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 26

Holders
74
Holders Change
-14
Holders Change %
-15.91%
% of All Funds
1.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
19
Reduced
16
Closed
26
Calls
$324K
Puts
$23K
Net Calls
+$301K
Net Calls Change
-$121K

Top Buyers

Rank Fund Capital Flow
1
GCP
GSA Capital Partners
United Kingdom
+$466K
2
Renaissance Technologies
Renaissance Technologies
New York
+$296K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$262K
4
Two Sigma Investments
Two Sigma Investments
New York
+$210K
5
RCM
Requisite Capital Management
Texas
+$74.3K

Top Sellers

Rank Fund Capital Flow
1
CWM
Curi Wealth Management
North Carolina
-$498K
2
GTC
Ghost Tree Capital
New York
-$469K
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$321K
4
Millennium Management
Millennium Management
New York
-$221K
5
YIH
Y-Intercept (HK)
Hong Kong
-$48K
Name Holding Trade Value Shares
Change 		Change in
Stake
BFM
76
Boothbay Fund Management
New York
– -$26K -4,892 Closed
AWP
77
Ascent Wealth Partners
New York
– -$22K -4,261 Closed
Citigroup
78
Citigroup
New York
– -$18K -3,487 Closed
Mercer Global Advisors
79
Mercer Global Advisors
Colorado
– -$16K -3,000 Closed
RC
80
RegentAtlantic Capital
New Jersey
– -$11K -2,066 Closed
Victory Capital Management
81
Victory Capital Management
Texas
– -$9K -1,729 Closed
SG Americas Securities
82
SG Americas Securities
New York
– -$8K -1,509 Closed
William Blair & Company
83
William Blair & Company
Illinois
– -$7K -1,420 Closed
AIP
84
Almanack Investment Partners
Pennsylvania
– -$6K -1,100 Closed
T. Rowe Price Associates
85
T. Rowe Price Associates
Maryland
– -$6K -1,081 Closed
National Bank of Canada
86
National Bank of Canada
Quebec, Canada
– -$3K -650 Closed
Squarepoint
87
Squarepoint
New York
– -$3K -536 Closed
KWS
88
Keystone Wealth Services
California
– -$3K -500 Closed
HFM
89
Hartford Financial Management
Connecticut
– -$1K -200 Closed
CA
90
CoreCap Advisors
Michigan
– -$1K -101 Closed
AIM
91
Axiom Investment Management
New York
– +$20 +4 New
CG
92
Cutler Group
California
– +$124 +25 +13%
1 2 3
4

NMTR Hedge Fund Activity: Q3 2022 in Review

74 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in 9 Meters Biopharma (NMTR) for Q3 2022, worth a combined $10.4M — down 20% from $13M a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of NMTR and 13 opened new positions — a net loss of 13 holders — while 16 trimmed existing stakes and 19 added.

The largest buyer was GSA Capital Partners, adding an estimated $466K. The largest seller was Curi Wealth Management, cutting an estimated $498K.

  • 74 institutional investors held 9 Meters Biopharma (NMTR) as of Q3 2022, down from 88 in Q2 2022.
  • Funds reported $10.4M of 9 Meters Biopharma stock for Q3 2022, down 20% quarter-over-quarter.
  • 13 funds opened new 9 Meters Biopharma positions in Q3 2022 and 26 closed out, a net change of -13 holders.
  • The largest 9 Meters Biopharma buyer in Q3 2022 was GSA Capital Partners, an estimated $466K added.
  • The largest 9 Meters Biopharma seller in Q3 2022 was Curi Wealth Management, an estimated $498K sold.

Based on aggregated 13F filings for Q3 2022.